Apurinic/apyrimidinic endonuclease 1 inhibits protein kinase C-mediated p66shc phosphorylation and vasoconstriction

Cardiovascular Research

Volumn 91, Issue 3, 2011, Pages 502-509

  Lee, Sang Ki ^a   Chung, Jae In ^a   Park, Myoung Soo ^a   Joo, Hee Kyoung ^a   Lee, Eun Ji ^a   Cho, Eun Jung ^a   Park, Jin Bong ^a   Ryoo, Sungwoo ^b   Irani, Kaikobad ^c,d   Jeon, Byeong Hwa ^a  

^a Chungnam National University   (South Korea)

^b Kangwon National University   (South Korea)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Apurinic apyrimidinic endonuclease1; Endothelial cells; Oxidized LDL; p66shc; Protein kinase C

Indexed keywords

APYRIMIDINIC ENDONUCLEASE 1; ENDONUCLEASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA II; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STIMULATION; CELL STRESS; CYTOPLASM; ENDOTHELIUM CELL; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; VASOCONSTRICTION;

ANIMALS; CELLS, CULTURED; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME ACTIVATORS; HUMANS; LIPOPROTEINS, LDL; MICE; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; VASOCONSTRICTION;

EID: 79960776994     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr095     Document Type: Article

References (43)

1. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999;402:309-313.
2. Camici GG, Cosentino F, Tanner FC, Luscher TF. The role of p66Shc deletion in age-associated arterial dysfunction and disease states. J Appl Physiol 2008;105: 1628-1631.
3. Cutler RL, Liu L, Damen JE, Krystal G. Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells. J Biol Chem 1993;268:21463-21465.
4. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992;70:93-104.
5. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992;360:689-692.
6. Kao AW,Waters SB, Okada S, Pessin JE. Insulin stimulates the phosphorylation of the 66- and 52-kilodalton Shc isoforms by distinct pathways. Endocrinology 1997;138: 2474-2480.
7. Yang CP, Horwitz SB. Taxol mediates serine phosphorylation of the 66-kDa Shc isoform. Cancer Res 2000;60:5171-5178.
8. Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002;295:2450-2452.
9. Skulachev VP. The p66shc protein: a mediator of the programmed death of an organism?. IUBMB Life 2000;49:177-180.
10. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 2006;69:36-45.
11. Giovannini C, Scazzocchio B, Matarrese P, Vari R, D'Archivio M, Di Benedetto R et al. Apoptosis induced by oxidized lipids is associated with up-regulation of p66Shc in intestinal Caco-2 cells: protective effects of phenolic compounds. J Nutr Biochem 2008;19:118-128.
12. Harja E, Chang JS, Lu Y, Leitges M, Zou YS, Schmidt AM et al. Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis. FASEB J 2009;23: 1081-1091.
13. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007;315:659-663.
14. Ceolotto G, Gallo A, Miola M, Sartori M, Trevisan R, Del Prato S et al. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes 1999;48:1316-1322.
15. Scivittaro V, Ganz MB, Weiss MF. AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells. Am J Physiol Renal Physiol 2000;278: F676-F683.
16. Braiman L, Sheffi-Friedman L, Bak A, Tennenbaum T, Sampson SR. Tyrosine phosphorylation of specific protein kinase C isoenzymes participates in insulin stimulation of glucose transport in primary cultures of rat skeletal muscle. Diabetes 1999;48: 1922-1929.
17. Bandyopadhyay G, Standaert ML, Galloway L, Moscat J, Farese RV. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerolsensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 1997;138:4721-4731.
18. Jeon BH, Irani K. APE1/Ref-1: versatility in progress. Antioxid Redox Signal 2009;11: 571-574.
19. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009;11:601-620.
20. Angkeow P, Deshpande SS, Qi B, Liu YX, Park YC, Jeon BH et al. Redox factor-1: an extra-nuclear role in the regulation of endothelial oxidative stress and apoptosis. Cell Death Differ 2002;9:717-725.
21. Ozaki M, Suzuki S, Irani K. Redox factor-1/APE suppresses oxidative stress by inhibiting the rac1 GTPase. FASEB J 2002;16:889-890.
22. Guo Y, Chen J, Zhao T, Fan Z. Granzyme K degrades the redox/DNA repair enzyme Ape1 to trigger oxidative stress of target cells leading to cytotoxicity. Mol Immunol 2008;45:2225-2235.
23. Kim CS, Son SJ, Kim EK, Kim SN, Yoo DG, Kim HS et al. Apurinic/apyrimidinic endonuclease1/ redox factor-1 inhibits monocyte adhesion in endothelial cells. Cardiovasc Res 2006;69:520-526.
24. Hall JL, Wang X, Van A, Zhao Y, Gibbons GH. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways. Circ Res 2001;88: 1247-1253.
25. Lee HM, Jeon BH, Won KJ, Lee CK, Park TK, Choi WS et al. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factorbeta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway. Circ Res 2009;104:219-227, 215p following 227.
26. Tanaka M, Sagawa S, Hoshi J, Shimoma F, Matsuda I, Sakoda K et al. Synthesis of anilino-monoindolylmaleimides as potent and selective PKCbeta inhibitors. Bioorg Med Chem Lett 2004;14:5171-5174.
27. Jeon BH, Gupta G, Park YC, Qi B, Haile A, Khanday FA et al. Apurinic/apyrmidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ Res 2004;95:902-910.
28. Song YJ, Lee JY, Joo HK, Kim HS, Lee SK, Lee KH et al. Tat-APE1/ref-1 protein inhibits TNF-alpha-induced endothelial cell activation. Biochem Biophys Res Commun 2008;368: 68-73.
29. Lee SK, Kim HS, Song YJ, Joo HK, Lee JY, Lee KH et al. Alteration of p66shc is associated with endothelial dysfunction in the abdominal aortic coarctation of rats. FEBS Lett 2008;582:2561-2566.
30. Bilder GE, Kasiewski CJ, Perrone MH. Phorbol-12,13-dibutyrate-induced vasoconstriction in vivo: characterization of response in genetic hypertension. J Pharmacol Exp Ther 1990;252:526-530.
31. Camici GG, Schiavoni M, Francia P, Bachschmid M, Martin-Padura I, Hersberger M et al. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci USA 2007;104: 5217-5222.
32. Tomilov AA, Bicocca V, Schoenfeld RA, Giorgio M, Migliaccio E, Ramsey JJ et al. Decreased superoxide production in macrophages of long-lived p66Shc knock-out mice. J Biol Chem 2010;285:1153-1165.
33. Graiani G, Lagrasta C, Migliaccio E, Spillmann F, Meloni M, Madeddu P et al. Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension 2005;46:433-440.
34. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P et al. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 2003;100:2112-2116.
35. Martin-Padura I, de Nigris F, Migliaccio E, Mansueto G, Minardi S, Rienzo M et al. p66Shc deletion confers vascular protection in advanced atherosclerosis in hypercholesterolemic apolipoprotein E knockout mice. Endothelium 2008;15:276-287.
36. Edwards AS, Faux MC, Scott JD, Newton AC. Carboxyl-terminal phosphorylation regulates the function and subcellular localization of protein kinase C betaII. J Biol Chem 1999;274:6461-6468.
37. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992;89:11059-11063.
38. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA. Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 2002;90:107-111.
39. Kouroedov A, Eto M, Joch H, Volpe M, Luscher TF, Cosentino F. Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 2004;110: 91-96.
40. Huang C, Chang JS, Xu Y, Li Q, Zou YS, Yan SF. Reduction of PKCbetaII activity in smooth muscle cells attenuates acute arterial injury. Atherosclerosis 2010;212: 123-130.
41. Jackson EB, Theriot CA, Chattopadhyay R, Mitra S, Izumi T. Analysis of nuclear transport signals in the human apurinic/apyrimidinic endonuclease (APE1/Ref1). Nucleic Acids Res 2005;33:3303-3312.
42. Tell G, Damante G, Caldwell D, Kelley MR. The intracellular localization of APE1/ Ref-1: more than a passive phenomenon?. Antioxid Redox Signal 2005;7:367-384.
43. Yuk JM, Yang CS, Shin DM, Kim KK, Lee SK, Song YJ et al. A dual regulatory role of apurinic/apyrimidinic endonuclease 1/redox factor-1 in HMGB1-induced inflammatory responses. Antioxid Redox Signal 2009;11:575-588.